ABOS·00509G209·US·equity·Healthcare - Biotechnology-Activist
ABOS (Acumen Pharmaceuticals, Inc.) is held by 42 institutional investors as of Q4 2025. Largest holders: RA CAPITAL MANAGEMENT, L.P. ($31.5M), FRANKLIN RESOURCES INC ($4.9M), FMR LLC ($4.3M). Net institutional sentiment: Mixed.
See how ABOS's score breaks down across 4 SEC sources
Data sourced from four SEC data sources: 13F, Form 4, 13D/13G, and STOCK Act. Not financial advice. Full disclaimer